APA (7th ed.) Citation

Stone, M. L., Chiappinelli, K. B., Li, H., Murphy, M., Travers, M. E., Topper, M. J., . . . Strissel, P. L. (2017). Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden. Proceedings of the National Academy of Sciences of the United States of America, 114(51), E10981. https://doi.org/10.1073/pnas.1712514114

Chicago Style (17th ed.) Citation

Stone, Meredith L., et al. "Epigenetic Therapy Activates Type I Interferon Signaling in Murine Ovarian Cancer to Reduce Immunosuppression and Tumor Burden." Proceedings of the National Academy of Sciences of the United States of America 114, no. 51 (2017): E10981. https://doi.org/10.1073/pnas.1712514114.

MLA (9th ed.) Citation

Stone, Meredith L., et al. "Epigenetic Therapy Activates Type I Interferon Signaling in Murine Ovarian Cancer to Reduce Immunosuppression and Tumor Burden." Proceedings of the National Academy of Sciences of the United States of America, vol. 114, no. 51, 2017, p. E10981, https://doi.org/10.1073/pnas.1712514114.